Status:
COMPLETED
Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE
Lead Sponsor:
Abbott Medical Devices
Collaborating Sponsors:
Guidant Corporation
Conditions:
Atherosclerotic Disease, Carotid
Eligibility:
All Genders
Phase:
NA
Brief Summary
This purpose of this study is to collect data on the FDA-approved ACCULINK(TM) Carotid Stent System and FDA 510(k)-cleared ACCUNET(TM) Embolic Protection System for the treatment of patients with athe...
Detailed Description
CAPTURE is a post-approval study to collect information on the safety and effectiveness of the ACCULINK and ACCUNET since the approval/clearance of these devices by the FDA. The ACCULINK stent is an e...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient's physician used an ACCULINK and/or ACCUNET
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00180492
Start Date
October 1 2004
End Date
August 1 2007
Last Update
October 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guidant Corporation
Santa Clara, California, United States, 95054